Skip to main content Skip to footer
Show/Hide Mobile Menu

​​​​​​​Who We Are

Baylor Scott & White offers patients with liver or pancreas tumors or chronic pancreatitis access to a full spectrum of treatment options. The Liver and Pancreas Disease Center opened in 1998 and is dedicated to treating patients with liver and pancreas cancer. The center coordinates each patient’s tumor management and plan of care among a team of specialists all located within one center.

Conditions Treated

  • Hepatocellular carcinoma (HCC)
  • Liver metastases
  • Neuroendocrine / carcinoid tumors
  • Bile duct cancer
  • Gall bladder cancer
  • Pancreatic cancer
  • Pancreatic cysts
  • Benign/Malignant pancreatic lesions
  • Acute/Chronic pancreatitis
  • Focal nodular hyperplasia (FNH)
  • Adenoma
  • Hemangioma
  • Polycystic liver disease
  • Liver cysts
  • ​Benign/Malignant liver lesions
  • Bile duct injury
  • Bile duct blockage
  • Biliary strictures/injuries
  • Challenging retroperitoneal tumors

Procedures Performed

  • Bile duct resections
  • Pancreaticoduodenectomy
  • Distal pancreatectomy
  • Total pancreatectomy
  • Complex pancreas/liver resection with vascular reconstruction

Why Choose Baylor Scott & White?

  • You will receive an expedited assessment and your case will be reviewed by a physician team of specialists within two weeks.
  • We will communicate directly with your primary care physician after your initial assessment and during ongoing care.  
  • Clinical coordinators schedule all of your evaluations and treatment in order to provide personalized care
  • Our team of specialists have the expertise and experience in treating these types of conditions.  
  • We are one of the few centers in the United States dedicated specifically to treat patients with liver and pancreas cancer.
  • The Baylor Liver and Pancreas Disease Center has been in existence since 1998. The program has treated 5,000 patients since its inception.
  • Baylor Scott & White  was one of the first facilities to use Elastography as a part of a research study as a method for testing liver stiffness.  Three years later, the procedure is now approved by the FDA.
  • Multidisciplinary tumor conference for both liver and pancreas – attended by radiology, surgery, advanced GI endoscopists, oncology.
  • Application of transplant techniques applied to resection of challenging tumors.
  • Complex pancreas and liver tumors with major vascular involvement, can be safely resected with vascular reconstruction.​

Serving all people by providing personalized health and wellness through exemplary care, education and research.


Learn more about our mission, vision and values »

Scroll To Top